Brittni Minafra, DO
Family Medicine · Summit, NJNPI 1295295186
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Lilly USA, LLC at 25.4% of the total. 2025 is the largest year on record at $256, 5.1 times the $50 reported in 2023. That places this record below the midpoint for family medicine clinicians in NJ, where the typical reported total is $394.
Across 28 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$122
- GSK$91
- Novo Nordisk$72
- Pfizer$48
- AbbVie$47
- Merck$32
- plus $69 from 4 others
What the payments were for
- Food & beverage$480100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 7 | $122 |
| GSK | 5 | $91 |
| Novo Nordisk | 4 | $72 |
| Pfizer | 3 | $48 |
| AbbVie | 3 | $47 |
| Merck | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $19 |
| Corium, LLC | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
How this compares
$480 in reported general payments places this provider in the 50th percentile of 2,084 family medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 38 | $466 |
| Losartan Potassium | 17 | $353 |
| Cefdinir | 15 | $300 |
| Amlodipine Besylate | 35 | $261 |
| Rosuvastatin Calcium | 26 | $245 |
| Alprazolam | 29 | $243 |
| Levothyroxine Sodium | 14 | $201 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $185 |
| Pantoprazole Sodium | 15 | $101 |
| Lisinopril | 14 | $82 |
| Cephalexin | 11 | $49 |
| Metformin Hcl | 12 | $37 |
| Azithromycin | 15 | $35 |
| Prednisone | 12 | $29 |
| Trazodone Hcl | 17 | $14 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Summit
- Mikhail VarshavskiChatham$1.4M
- Janet ColeFar Hills$466K
- Matthew PintoMarlton$239K
- Jennifer CaudleSewell$226K
- Jeffrey LevineNew Brunswick$195K
- Jennifer AmicoNew Brunswick$159K
- Dena LacaraFairfield$122K
- Gaurang BrahmbhattHoboken$89K
- Juan LatorreHoboken$71K
- Sally MravcakJersey City$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.